MARKET

ABBV

ABBV

Abbvie Inc
NYSE
226.82
+4.00
+1.80%
After Hours: 226.82 0 0.00% 19:57 12/19 EST
OPEN
222.95
PREV CLOSE
222.82
HIGH
229.47
LOW
222.35
VOLUME
18.97M
TURNOVER
--
52 WEEK HIGH
243.06
52 WEEK LOW
160.33
MARKET CAP
400.88B
P/E (TTM)
171.15
1D
5D
1M
3M
1Y
5Y
1D
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal
Benzinga · 21h ago
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts
Benzinga · 1d ago
Market Voices: Trump on Venezuela, CPI data issues, drug pricing deals
Seeking Alpha · 1d ago
Pharma's $370B Bet on America: The ETF Plays for 2026
NASDAQ · 1d ago
Pfizer Down After It Issues Muted 2026 Outlook: How to Play the Stock
NASDAQ · 1d ago
Trump to announce new drug-pricing deals later today
MarketWatch · 1d ago
'Several top drugmakers to lower US prices for some drugs-sources' - Reuters
Benzinga · 1d ago
AbbVie, Bristol Myers, Merck among latest to announce U.S. drug pricing deals: Reuters
Seeking Alpha · 1d ago
More
About ABBV
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.